<link rel="stylesheet" href="styles.cf390c6bfbe7555f.css"> Skip to main content

Study on drug release behaviour of CDHA/chitosan nanocomposites-Effect of CDHA nanoparticles

dc.citation.epage95en_US
dc.citation.issue1en_US
dc.citation.spage88en_US
dc.citation.volume112en_US
dc.citation.woscount21
dc.contributor.authorLiu, TYen_US
dc.contributor.authorChen, SYen_US
dc.contributor.authorLi, JHen_US
dc.contributor.authorLiu, DMen_US
dc.contributor.department材料科學與工程學系zh_TW
dc.contributor.departmentDepartment of Materials Science and Engineeringen_US
dc.date.accessioned2014-12-08T15:16:45Z
dc.date.available2014-12-08T15:16:45Z
dc.date.issued2006-05-01en_US
dc.description.abstractTo explore the effect of nanofiller-polymer interaction on the drug release behaviour from a monolithic membrane prepared by Ca-deficient hydroxyapatite (CDHA)/chitosan nanocomposite, release kinetics was investigated in terms of different synthetic processes, i.e. in situ and ex situ routes, and various amounts of CDHA. It was found that a higher value of diffusion exponent (n) was obtained for the membranes in situ synthesized compared with those ex situ prepared. In addition, the it value of the membranes in situ synthesized increased with increasing CDHA amount, which remained in the range below 10wt.%. However, as CDHA content exceeded 30%, the n value remained constant. It indicates that the drug diffusion mechanism is altered by the CDHA-chitosan interaction which is strongly influenced by both the synthesis process and the concentration of the CDHA nanofiller in the membrane. On the other hand, a lower permeability (P) value of the membranes was observed for those prepared via the in situ process. Furthermore, P value decreased and increased with increasing CDHA amount in the range below and above 10 wi.%, respectively. It demonstrates that CDHA nanofillers act either diffusion barrier or diffusion enhancer for the CDHA/chitosan membranes, which is determined by the concentration of CDHA nanofiller and the synthesis route of nanocomposite. (c) 2006 Elsevier B.V All rights reserved.en_US
dc.identifier.doi10.1016/j.jconrel.2006.01.017en_US
dc.identifier.issn0168-3659en_US
dc.identifier.journalJOURNAL OF CONTROLLED RELEASEen_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.jconrel.2006.01.017en_US
dc.identifier.urihttps://ir.lib.nycu.edu.tw/handle/11536/12328
dc.identifier.wosnumberWOS:000237263100011
dc.language.isoen_USen_US
dc.subjectchitosanen_US
dc.subjectCa-deficient hydroxyapatiteen_US
dc.subjectnanocompositeen_US
dc.subjectdrug releaseen_US
dc.subjectin situ processen_US
dc.titleStudy on drug release behaviour of CDHA/chitosan nanocomposites-Effect of CDHA nanoparticlesen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
000237263100011.pdf
Size:
416.08 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: